192 related articles for article (PubMed ID: 16963563)
1. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity.
Oltean S; Sorg BS; Albrecht T; Bonano VI; Brazas RM; Dewhirst MW; Garcia-Blanco MA
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14116-21. PubMed ID: 16963563
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
[TBL] [Abstract][Full Text] [Related]
3. Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice.
Baraniak AP; Chen JR; Garcia-Blanco MA
Mol Cell Biol; 2006 Feb; 26(4):1209-22. PubMed ID: 16449636
[TBL] [Abstract][Full Text] [Related]
4. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
5. Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
Oltean S; Febbo PG; Garcia-Blanco MA
Clin Exp Metastasis; 2008; 25(6):611-9. PubMed ID: 18523850
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
7. Identification of an intronic splicing enhancer essential for the inclusion of FGFR2 exon IIIc.
Seth P; Miller HB; Lasda EL; Pearson JL; Garcia-Blanco MA
J Biol Chem; 2008 Apr; 283(15):10058-67. PubMed ID: 18256031
[TBL] [Abstract][Full Text] [Related]
8. FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.
Guo M; Liu W; Serra S; Asa SL; Ezzat S
Cancer Res; 2012 Apr; 72(8):2017-27. PubMed ID: 22345151
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo.
Somarelli JA; Schaeffer D; Bosma R; Bonano VI; Sohn JW; Kemeny G; Ettyreddy A; Garcia-Blanco MA
RNA; 2013 Jan; 19(1):116-27. PubMed ID: 23185039
[TBL] [Abstract][Full Text] [Related]
10. Imaging the alternative silencing of FGFR2 exon IIIb in vivo.
Bonano VI; Oltean S; Brazas RM; Garcia-Blanco MA
RNA; 2006 Dec; 12(12):2073-9. PubMed ID: 17068207
[TBL] [Abstract][Full Text] [Related]
11. A stem structure in fibroblast growth factor receptor 2 transcripts mediates cell-type-specific splicing by approximating intronic control elements.
Baraniak AP; Lasda EL; Wagner EJ; Garcia-Blanco MA
Mol Cell Biol; 2003 Dec; 23(24):9327-37. PubMed ID: 14645542
[TBL] [Abstract][Full Text] [Related]
12. MAZ elements alter transcription elongation and silencing of the fibroblast growth factor receptor 2 exon IIIb.
Robson-Dixon ND; Garcia-Blanco MA
J Biol Chem; 2004 Jul; 279(28):29075-84. PubMed ID: 15126509
[TBL] [Abstract][Full Text] [Related]
13. Characterization of sequences and mechanisms through which ISE/ISS-3 regulates FGFR2 splicing.
Hovhannisyan RH; Warzecha CC; Carstens RP
Nucleic Acids Res; 2006; 34(1):373-85. PubMed ID: 16410617
[TBL] [Abstract][Full Text] [Related]
14. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis.
Cha JY; Lambert QT; Reuther GW; Der CJ
Mol Cancer Res; 2008 Mar; 6(3):435-45. PubMed ID: 18337450
[TBL] [Abstract][Full Text] [Related]
15. The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs.
Jones RB; Wang F; Luo Y; Yu C; Jin C; Suzuki T; Kan M; McKeehan WL
J Biol Chem; 2001 Feb; 276(6):4158-67. PubMed ID: 11042206
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.
Zhu X; Lee K; Asa SL; Ezzat S
Am J Pathol; 2007 May; 170(5):1618-28. PubMed ID: 17456767
[TBL] [Abstract][Full Text] [Related]
17. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.
Yan G; Fukabori Y; McBride G; Nikolaropolous S; McKeehan WL
Mol Cell Biol; 1993 Aug; 13(8):4513-22. PubMed ID: 7687739
[TBL] [Abstract][Full Text] [Related]
18. The missense mutation W290R in Fgfr2 causes developmental defects from aberrant IIIb and IIIc signaling.
Mai S; Wei K; Flenniken A; Adamson SL; Rossant J; Aubin JE; Gong SG
Dev Dyn; 2010 Jun; 239(6):1888-900. PubMed ID: 20503384
[TBL] [Abstract][Full Text] [Related]
19. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
[TBL] [Abstract][Full Text] [Related]
20. A Non-sequence-specific double-stranded RNA structural element regulates splicing of two mutually exclusive exons of fibroblast growth factor receptor 2 (FGFR2).
Muh SJ; Hovhannisyan RH; Carstens RP
J Biol Chem; 2002 Dec; 277(51):50143-54. PubMed ID: 12393912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
